
    
      This study is designed to evaluated implementation of PrEP treatment as a part of the general
      HIV preventive program in Norway. The target groups are mainly MSM and transgender persons at
      high risk of HIV infection, as well as other subjects at risk of HIV infection due to their
      sexual practices.

      Objectives include assessment of the following:

        1. Assess the impact of PrEP on the sexual and psychological health of PrEP users Incidence
           of sexually transmitted infections (STIs) in PrEP users compared to those not taking
           PrEP

        2. Assessment of drug compliance

        3. Incidence of HIV seroconversion despite PrEP

        4. Frequency and development of drug resistance in subjects who HIV-seroconvert (if any)
    
  